Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
IMI brings together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators and offer funding for collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges.
Característiques principals
  • Topic 1: Returning clinical trial data to study participants within a GDPR compliant and approved ethical framework
  • Topic 2: Modelling the impact of monoclonal antibodies and vaccines on the reduction of antimicrobial resistance. This topic is part of IMI's Antimicrobial Resistance (AMR) Accelerator programme.
  • Topic 3: A platform for accelerating biomarker discovery and validation to support therapeutics development for neurodegenerative diseases
  • Topic 4: Optimal treatment for patients with solid tumours in Europe through artificial intelligence
  • Topic 5 Shortening the path to rare disease diagnosis by using new born genetic screening and digital technologies
  • Topic 6: Behavioural model of factors affecting patient adherence
    • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
    • Carol Barnwell, cbarnwell@imim.es. Ext.: 1670
    • Marta López, mlopez4@imim.es Ext.: 1576
    Convocatòria (URL)
    https://www.imi.europa.eu/apply-funding/open-calls/imi2-call-23
    Dotació
    Financial contribution from IMI2 JU from EUR 3.260.000 to 11.940.000

    Arxius

    Arxiu
    IMI2_Call23_CallText.pdf